Ligand-specific regulation of the endogenous Mu-opioid receptor by chronic treatment with Mu-opioid peptide agonists

Marianna Murányi, Resat Cinar, Orsolya Kékesi, Erika Birkás, Gabriella Fábián, Beáta Bozó, András Zentai, Géza Tóth, Emese Gabriella Kicsi, Mónika MácSai, Roberta Dochnal, Gyula Szabó, Mária Szücs

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Since the discovery of the endomorphins (EM), the postulated endogenous peptide agonists of the mu-opioid receptors, several analogues have been synthesized to improve their binding and pharmacological profiles. We have shown previously that a new analogue, cis-1S,2R-aminocyclohexanecarboxylic acid 2-endomorphin-2 (ACHC-EM2), had elevated mu-receptor affinity, selectivity, and proteolytic stability over the parent compound. In the present work, we have studied its antinociceptive effects and receptor regulatory processes. ACHC-EM2 displayed a somewhat higher (60%) acute antinociceptive response than the parent peptide, EM2 (45%), which peaked at 10 min after intracerebroventricular (icv) administration in the rat tail-flick test. Analgesic tolerance developed to the antinociceptive effect of ACHC-EM2 upon its repeated icv injection that was complete by a 10-day treatment. This was accompanied by attenuated coupling of mu-sites to G-proteins in subcellular fractions of rat brain. Also, the density of mu-receptors was upregulated by about 40% in the light membrane fraction, with no detectable changes in surface binding. Distinct receptor regulatory processes were noted in subcellular fractions of rat brains made tolerant by the prototypic full mu-agonist peptide, DAMGO, and its chloromethyl ketone derivative, DAMCK. These results are discussed in light of the recently discovered phenomenon, that is, the "so-called biased agonism" or "functional selectivity".

Original languageEnglish
Article number501086
JournalBioMed research international
Volume2013
DOIs
Publication statusPublished - Dec 1 2013

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Murányi, M., Cinar, R., Kékesi, O., Birkás, E., Fábián, G., Bozó, B., Zentai, A., Tóth, G., Kicsi, E. G., MácSai, M., Dochnal, R., Szabó, G., & Szücs, M. (2013). Ligand-specific regulation of the endogenous Mu-opioid receptor by chronic treatment with Mu-opioid peptide agonists. BioMed research international, 2013, [501086]. https://doi.org/10.1155/2013/501086